Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Sanford Paul A	2. Date of Event Requiring Statement (MM/DD/YYYY) 9/27/2021	3. Issuer Name and Ticker or Trading Symbol Cigna Corp [CI]
(Last)        (First)        (Middle) 900 COTTAGE GROVE ROAD	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) EVP Operations /
(Street) BLOOMFIELD, CT 06002       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $.01 Par Value	8537.0000	D
Common Stock, $.01 Par Value	253.9100 (1)	I	By 401(k)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	2/28/2018 (2)	2/28/2027	Common Stock, $.01 Par Value	95.0000	$149.1350	D
Employee Stock Option (Right to Buy)	2/27/2020 (3)	2/27/2029	Common Stock, $.01 Par Value	1826.0000	$183.4405	D
Employee Stock Option (Right to Buy)	2/26/2021 (4)	2/26/2030	Common Stock, $.01 Par Value	1847.0000	$192.0200	D
Employee Stock Option (Right to Buy)	2/28/2019 (2)	2/28/2028	Common Stock, $.01 Par Value	3092.0000	$197.3500	D
Employee Stock Option (Right to Buy)	3/1/2022 (5)	2/24/2031	Common Stock, $.01 Par Value	2677.0000	$213.8000	D

Explanation of Responses:
(1)	Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
(2)	This option is fully vested.
(3)	This option vests in three equal annual installments. The first installment became exercisable on February 27, 2020, the second installment became exercisable on February 27, 2021 and the third installment will become exercisable on February 27, 2022.
(4)	This option vests in three equal annual installments. The first installment became exercisable on February 26, 2021, and the next two installments become exercisable on February 26, 2022 and February 26, 2023.
(5)	This option vests in three equal annual installments beginning March 1, 2022.

Remarks: Exhibit List: EX-24 Power of Attorney poasanford.txt

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Sanford Paul A 900 COTTAGE GROVE ROAD BLOOMFIELD, CT 06002			EVP Operations

Signatures
By: Jill M. Stadelman, attorney-in-fact		10/7/2021
**Signature of Reporting Person		Date